Finance Watch: CARGO Gets A Lukewarm Reception After Stock Market Debut
Offering Is 21st Biopharma IPO In The US In 2023
Public Company Edition: CARGO Therapeutics grossed $281.3m, giving it the fifth-largest biopharma IPO this year. Also, Alkermes completed its cancer business spinout as Mural Oncology, which launched with $275m, and Xencor sold Ultomiris and Monjuvi royalties for $215m.
